Showing results (971-980 of 1,158) with videos related to

Sort By:
Pageof 116
The French Journal of Urology|June 1, 2024
Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study)Carole Helissey, Denis Maillet, Bérengère Narciso, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2022
Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's DiseaseStéphane Prange, Elise Metereau, Audrey Maillet, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 4, 2000
[Neurodevelopmental outcome of premature infants born at less than 33 weeks of gestational age and not cerebral palsy at the age of 5 years]A Burguet, E Monnet, P Roth, et al.
NAR Genomics and Bioinformatics|August 23, 2023
BioConvert: a comprehensive format converter for life sciencesHugo Caro, Sulyvan Dollin, Anne Biton, et al.
Annals of Surgical Oncology|October 21, 2015
Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter StudyMarianne Maillet, Olivier Glehen, Jerome Lambert, et al.
Journal of Allied Health|September 11, 2017
Employers' Viewpoint on Clinical EducationChristopher W O'Brien, Roy Anderson, Benjamin Ayzenberg, et al.
Frontiers in Immunology|June 16, 2020
Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma PatientsAdrien Bosseboeuf, Célia Seillier, Nicolas Mennesson, et al.
Journal of Interprofessional Care|February 11, 2023
Comparing the implementation of advanced access strategies among primary health care providersMylaine Breton, Nadia Deville-Stoetzel, Isabelle Gaboury, et al.
Bulletin Du Cancer|September 5, 2024
[Metastatic castration-resistant prostate cancer and PARP inhibitors: From tumor genomics to new therapeutic combinations]Stéphane Oudard, Marc-Olivier Timsit, Denis Maillet, et al.
The French Journal of Urology|October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinionDelphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Pageof 116